151 related articles for article (PubMed ID: 1782350)
1. Hepatotoxicity after 3'-hydroxyacetanilide administration to buthionine sulfoximine pretreated mice.
Tirmenstein MA; Nelson SD
Chem Res Toxicol; 1991; 4(2):214-7. PubMed ID: 1782350
[TBL] [Abstract][Full Text] [Related]
2. p-Dichlorobenzene-induced hepatotoxicity in mice depleted of glutathione by treatment with buthionine sulfoximine.
Mizutani T; Nakahori Y; Yamamoto K
Toxicology; 1994; 94(1-3):57-67. PubMed ID: 7801330
[TBL] [Abstract][Full Text] [Related]
3. Role of glutathione turnover in drug sulfation: differential effects of diethylmaleate and buthionine sulfoximine on the pharmacokinetics of acetaminophen in the rat.
Galinsky RE
J Pharmacol Exp Ther; 1986 Jan; 236(1):133-9. PubMed ID: 3941389
[TBL] [Abstract][Full Text] [Related]
4. Effects of buthionine sulfoximine and diethyl maleate on glutathione turnover in the channel catfish.
Gallagher EP; Hasspieler BM; Di Giulio RT
Biochem Pharmacol; 1992 May; 43(10):2209-15. PubMed ID: 1350905
[TBL] [Abstract][Full Text] [Related]
5. Effect of modulators of glutathione synthesis on the hepatotoxicity of 2-methylfuran.
Ravindranath V; Boyd MR
Biochem Pharmacol; 1991 May; 41(9):1311-8. PubMed ID: 2018563
[TBL] [Abstract][Full Text] [Related]
6. Effect of glutathione levels on aflatoxin B1-DNA binding in livers and kidneys of male rats and hamsters pretreated with buthionine sulfoximine and dimethylmaleate.
Gopalan-Kriczky P; Hiruma S; Lotlikar PD
Cancer Lett; 1994 Jan; 76(1):25-30. PubMed ID: 8124663
[TBL] [Abstract][Full Text] [Related]
7. Subcellular glutathione contents in isolated hepatocytes treated with L-buthionine sulfoximine.
Romero FJ; Sies H
Biochem Biophys Res Commun; 1984 Sep; 123(3):1116-21. PubMed ID: 6487323
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of glutathione synthesis in the liver leads to S-adenosyl-L-methionine synthetase reduction.
Corrales F; Ochoa P; Rivas C; Martin-Lomas M; Mato JM; Pajares MA
Hepatology; 1991 Sep; 14(3):528-33. PubMed ID: 1874498
[TBL] [Abstract][Full Text] [Related]
9. Hepatotoxicity of eugenol in mice depleted of glutathione by treatment with DL-buthionine sulfoximine.
Mizutani T; Satoh K; Nomura H; Nakanishi K
Res Commun Chem Pathol Pharmacol; 1991 Feb; 71(2):219-30. PubMed ID: 2047567
[TBL] [Abstract][Full Text] [Related]
10. Subcellular binding and effects on calcium homeostasis produced by acetaminophen and a nonhepatotoxic regioisomer, 3'-hydroxyacetanilide, in mouse liver.
Tirmenstein MA; Nelson SD
J Biol Chem; 1989 Jun; 264(17):9814-9. PubMed ID: 2524496
[TBL] [Abstract][Full Text] [Related]
11. The effect of depletion of nonprotein sulfhydryls by diethyl maleate plus buthionine sulfoximine on renal uptake of mercury in the rat.
Baggett JM; Berndt WO
Toxicol Appl Pharmacol; 1986 May; 83(3):556-62. PubMed ID: 3705075
[TBL] [Abstract][Full Text] [Related]
12. Buthionine sulfoximine pretreatment potentiates the effect of isolated lung perfusion with doxorubicin.
Port JL; Hochwald SN; Wang HY; Burt ME
Ann Thorac Surg; 1995 Aug; 60(2):239-43; discussion 244. PubMed ID: 7544099
[TBL] [Abstract][Full Text] [Related]
13. S-adenosylmethionine protects against acetaminophen hepatotoxicity in two mouse models.
Bray GP; Tredger JM; Williams R
Hepatology; 1992 Feb; 15(2):297-301. PubMed ID: 1735533
[TBL] [Abstract][Full Text] [Related]
14. The effect of buthionine sulfoximine, an inhibitor of glutathione synthesis, on hepatic drug metabolism in the male mouse.
White RD; Norton R; Bus JS
Toxicol Lett; 1984 Oct; 23(1):25-32. PubMed ID: 6485015
[TBL] [Abstract][Full Text] [Related]
15. Modification of butylated hydroxytoluene-induced pulmonary toxicity in mice by diethyl maleate, buthionine sulfoximine, and cysteine.
Mizutani T; Nomura H; Yamamoto K; Tajima K
Toxicol Lett; 1984 Dec; 23(3):327-31. PubMed ID: 6523525
[TBL] [Abstract][Full Text] [Related]
16. Relationship between glutathione concentration and metabolism of the pyrrolizidine alkaloid, monocrotaline, in the isolated, perfused liver.
Yan CC; Huxtable RJ
Toxicol Appl Pharmacol; 1995 Jan; 130(1):132-9. PubMed ID: 7839360
[TBL] [Abstract][Full Text] [Related]
17. Hepatotoxicity of eugenol and related compounds in mice depleted of glutathione: structural requirements for toxic potency.
Mizutani T; Satoh K; Nomura H
Res Commun Chem Pathol Pharmacol; 1991 Jul; 73(1):87-95. PubMed ID: 1882130
[TBL] [Abstract][Full Text] [Related]
18. Glutathione metabolism in the lung: inhibition of its synthesis leads to lamellar body and mitochondrial defects.
Mårtensson J; Jain A; Frayer W; Meister A
Proc Natl Acad Sci U S A; 1989 Jul; 86(14):5296-300. PubMed ID: 2748585
[TBL] [Abstract][Full Text] [Related]
19. Enhancement of cisplatin toxicity by buthionine sulfoximine, a glutathione-depleting agent, in mice.
Ishikawa M; Takayanagi Y; Sasaki K
Res Commun Chem Pathol Pharmacol; 1990 Jan; 67(1):131-41. PubMed ID: 2326543
[TBL] [Abstract][Full Text] [Related]
20. L-Buthionine (S,R) sulfoximine depletes hepatic glutathione but protects against ethanol-induced liver injury.
Donohue TM; Curry-McCoy TV; Todero SL; White RL; Kharbanda KK; Nanji AA; Osna NA
Alcohol Clin Exp Res; 2007 Jun; 31(6):1053-60. PubMed ID: 17428293
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
